Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Aug 15;11(8):1188.
doi: 10.3390/cancers11081188.

Anaplastic Thyroid Cancer: Clinical Picture of the Last Two Decades at a Single Oncology Referral Centre and Novel Therapeutic Options

Joana Simões-Pereira  1   2   3 , Ricardo Capitão  4 , Edward Limbert  5 , Valeriano Leite  5   6   7
Affiliations

Anaplastic Thyroid Cancer: Clinical Picture of the Last Two Decades at a Single Oncology Referral Centre and Novel Therapeutic Options

Joana Simões-Pereira et al. Cancers (Basel). .

Abstract

Anaplastic thyroid cancer (ATC) is a rare tumour but also one of the most lethal malignancies. Therapeutic modalities have usually been limited, but clinical trials with new drugs are now being implemented. The aims of this study were to analyse the clinical presentation, therapeutic modalities and independent prognostic factors for survival. We also reviewed the most recent literature on novel ATC therapies. We performed a retrospective analysis of 79 patients diagnosed between 2000 and 2018. Variables with impact on survival were identified using the Cox proportional-hazard regression model. At presentation, 6.3% had thyroid-confined disease, 30.4% evidenced extrathyroidal extension and 60.8% were already metastatic. Surgery was feasible in 41.8% and radiotherapy was applied to 35.4%, with those receiving >45 Gy having longer estimated survival (p = 0.020). Chemotherapy, either conventional or with tyrosine kinase inhibitors, was performed in 17.7% and 7.6%, respectively. Multimodality therapy with surgery, radiotherapy and chemotherapy/tyrosine kinase inhibitors (TKI) had the greatest impact on disease specific survival (DSS), providing a risk reduction of death of 96.9% (hazard ratio (HR) = 0.031, 0.005-0.210, p < 0.001). We concluded that most of these patients join reference centres at advanced stages of disease and multimodality treatment may offer the best chances for prolonging survival.

Keywords: anaplastic thyroid cancer; immune checkpoint inhibitors; survival; tyrosine kinase inhibitors.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interests.

Figures

Figure 1
Figure 1
Anaplastic thyroid cancer incidence.
Figure 2
Figure 2
Survival functions regarding surgical margins (R0 vs. R1 vs. R2).
Figure 3
Figure 3
Survival functions regarding radiotherapy dose (≤45 Gy vs. > 45 Gy).
See this image and copyright information in PMC

References

    1. Ragazzi M., Ciarrocchi A., Sancisi V., Bisagni A., Piana S. Update on anaplastic thyroid carcinoma: Morphological, molecular, and genetic features of the most aggressive thyroid cancer. Int. J. Endocrinol. 2014;2014:79083. doi: 10.1155/2014/790834. - DOI - PMC - PubMed
    1. Smallridge R.C., Marlow L.A., Copland J.A. Anaplastic thyroid cancer: Molecular pathogenesis and emerging therapies. Endocr. Relat. Cancer. 2009;16:17–44. doi: 10.1677/ERC-08-0154. - DOI - PMC - PubMed
    1. Molinaro E., Romei C., Biagini A., Sabini E., Agate L., Mazzeo S., Materazzi G., Sellari-Franceschini S., Ribechini A., Torregrossa L., et al. Anplastic thyroid carcinoma: From clinicopathology to genetics and advanced therapies. Nat. Rev. Endocrinol. 2017;13:644–660. doi: 10.1038/nrendo.2017.76. - DOI - PubMed
    1. Smallridge R.C., Ain K.B., Asa S.L., Bible K.C., Brierley J.D., Burman K.D., Kebebew E., Lee N.Y., Nikiforov Y.E., Shah M.H., et al. American Thyryoid Association Anaplastic Thyroid Cancer Guidelines Taskforce. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. Thyroid. 2012;22:1104–1139. doi: 10.1089/thy.2012.0302. - DOI - PubMed
    1. Davies L., Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973–2002. J. Am. Med. Assoc. 2006;295:2164–2167. doi: 10.1001/jama.295.18.2164. - DOI - PubMed